ISSUE 90 I JANUARY 2020 ACCESS DENIED: the impact trial Is NHS England putting patients at risk by restricting access to pre-exposure prophylaxis drugs? Accessing PrEP in the UK The burden of endometriosis China: the new R&D powerhouse In association with The burden of endometriosis The scourge of fake medicines in Africa Big pharma's presence in China In association with 02/21/2020 11:33:22